New blood test could speed up TB diagnosis

NCT ID NCT07170735

Recruiting now Diagnosis Sponsor: Chinese University of Hong Kong Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether measuring TB DNA in blood and urine can help diagnose tuberculosis and track treatment progress. Current TB tests can be slow or require invasive procedures. The trial will enroll 85 people with active TB, latent TB, or no TB to see how accurate the new test is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Plasma and urine MTB cfDNA assay
What this could lead to: If successful, this could lead to a simple blood or urine test for faster, non-invasive TB diagnosis and treatment monitoring.
What could go wrong: This is an early exploratory study with only 85 participants. The test may not be accurate enough or may not work for all types of TB.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LATENT TUBERCULOSIS INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

latent tuberculosis infection tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS

Contacts and locations

Locations

Prince of Wales Hospital
NOT_YET_RECRUITING

Hong Kong, Hong Kong, Hong Kong
Prince of Wales Hospital
RECRUITING

Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.